PHARMADEVILLE
ActivePHARMADEVILLE has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €47k and a net result of €-17k. Equity remains stable across the filed fiscal years (±0.2% per year). Its solvency ranks better than 36% of 18024 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
17
/ 100
Critical▼ -72 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0▼-68
Solvency24▼-40
Growth32▼-46
Stability100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity tight (current ratio 1.01 against 1.53 in 2024), and 81.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
18.4%
Return on assets
-6.7%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
32 d early
2024
31 d early
2023
13 d late
2022
16 d late
2021
3 d early
2020
2 d early
2019
29 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€47k▼ 40.6%
2024 · €80k
2018: €71k
2019: €58k
2020: €70k
2021: €80k
2022: €88k
2023: €69k
2024: €80k
2018 → 2025
Total assets
€258k▲ 7.9%
2024 · €239k
2018: €463k
2019: €435k
2020: €391k
2021: €364k
2022: €322k
2023: €257k
2024: €239k
2018 → 2025
Net result
€-17k
2024 · €11k
2018: €79
2019: €1k
2020: €30k
2021: €10k
2022: €8k
2023: €-20k
2024: €11k
2018 → 2025
Working capital
€2k▼ 96.1%
2024 · €48k
2018: €-55k
2019: €-59k
2020: €-31k
2021: €28k
2022: €44k
2023: €50k
2024: €48k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€80k-€88k▲ 10.6%€69k▼ 22.1%€80k▲ 15.7%€47k▼ 40.6%
Operating result€24k-€18k▼ 26.1%€-13k€16k€-13k
Net result€10k-€8k▼ 12.7%€-20k€11k€-17k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €13k after €16k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €258k
Fixed assets
€112k▲ 10.8%
Current assets
€146k▲ 5.8%
Equity and liabilities €258k
Equity
€47k▼ 40.6%
Debt
€211k▲ 32.2%
The debt ratio rises from 66.7% to 81.6%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€7k▼
2024 · €26k
Cash flow
€3k▼
2024 · €21k
Solvency
18.4%▼
2024 · 33.3%
Current ratio
1.01▼
2024 · 1.53
Quick ratio
0.39▼
2024 · 0.64
Debt / equity
4.45▲
2024 · 2.00
ROE
-36.7%▼
2024 · 13.5%
ROA
-6.7%▼
2024 · 4.5%
Interest coverage
1.49▼
2024 · 4.90
Debt
€211k▲
2024 · €159k
Debt ≤ 1 year
€144k▲
2024 · €90k
Debt > 1 year
€66k▼
2024 · €69k
Staff costs
€32k▲
2024 · €25k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€239k€258k▲
Fixed assets21/28€101k€112k▲
Tangible fixed assets22/27€101k€112k▲
Land and buildings22€90k€83k▼
Plant, machinery and equipment23€10k€7k▼
Furniture and vehicles24-€21k
Current assets29/58€138k€146k▲
Stocks and contracts in progress3€81k€90k▲
Stocks30/36€81k€90k▲
Amounts receivable within one year40/41€44k€47k▲
Trade receivables40€38k€44k▲
Other amounts receivable41€6k€3k▼
Cash at bank and in hand54/58€13k€9k▼
Deferred charges and accrued income490/1€466€929▲
Equity and liabilities
Total equity and liabilities10/49€239k€258k▲
Equity10/15€80k€47k▼
Contributions10/11€19k€19k=
Reserves13€51k€36k▼
Tax-exempt reserves132€1k€1k=
Distributable reserves133€50k€35k▼
Profit (loss) carried forward14€10k€-7k▼
Amounts payable17/49€159k€211k▲
Amounts payable after more than one year17€69k€66k▼
Financial debts170/4€69k€66k▼
Amounts payable within one year42/48€90k€144k▲
Current portion of amounts payable after more than one year42€24k€30k▲
Financial debts43-€24k
Credit institutions430/8-€24k
Trade debts44€63k€68k▲
Suppliers440/4€63k€68k▲
Taxes, remuneration and social security45€3k€7k▲
Remuneration and social security454/9€3k€7k▲
Other amounts payable47/48-€15k
Accrued charges and deferred income492/3€360-
Income statement
Code20242025
Remuneration, social security and pensions62€25k€32k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€20k▲
Other operating charges640/8€2k€3k▲
Gross operating margin9900€53k€43k▼
Operating profit (loss)9901€16k€-13k▼
Financial income75/76B€42€134▲
Recurring financial income75€42€134▲
Financial charges65/66B€5k€5k▼
Recurring financial charges65€5k€5k▼
Profit (loss) for the period before taxes9903€11k€-17k▼
Profit (loss) for the period9904€11k€-17k▼
Profit (loss) for the period to be appropriated9905€11k€-17k▼
Appropriation of the result
Profit (loss) to be appropriated9906€10k€-7k▼
Profit (loss) brought forward from the previous period14P€-933€10k▲
Transfer from equity791/2-€15k
Profit to be distributed694/7-€15k
Return on contributions (dividend)694-€15k
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Back to profitnet €11k
Net result €11k after one loss-making year.
13-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 13 days late
2023
31-12
Financial
Weakest financial yearnet €-20k ▼331%
Net result drops to €-20k, the lowest in the series; recovery starts the following year.
16-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 16 days late
2022
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
29-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Highest result since 2018net €30k ▲2587%
Operating result €47k, net result €30k, both a record.
02-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
19-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
27-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bernissart · 1 establishment unit since 2000
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Ville(POM) 77322 BernissartGround area
2,419 m²
Building footprint
315 m²
Volume, LiDAR
1,280 m³
2 parcels, Wallonia · tallest building 9.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Rue de Ville(POM) 5 7, 7322 Bernissart
since 20002.100.904.687
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 51049B0384/00H000 | Wallonia | 1,217 m² | 1 · 129 m² | - |
| 51049B0315/00L000indicative | Wallonia | 1,202 m² | 1 · 186 m² | 9.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
1 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Viventop
BE 0825.370.327
Sambreville · Eq €47k
MINOPHARMA
BE 0452.440.563
Walcourt · Eq €47k
AXCOFARMA
BE 0889.949.363
Diepenbeek · Eq €47k
JAHVY
BE 1007.609.472
Buggenhout · Eq €47k
SULAYMAN
BE 1001.603.687
Enghien · Eq €47k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 2,680 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-07-2000
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.